MedPath

Breast Cancer and Quality of Life

Completed
Conditions
Breast Cancer
Interventions
Behavioral: interview
Registration Number
NCT01661816
Lead Sponsor
Centre Oscar Lambret
Brief Summary

The study aims to analyse and decode interviews of patient with breast cancer, and then established according a multidimensional profile specific to the population and to create a questionnaire tha will allow a practical and qualitative evaluation of the quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
171
Inclusion Criteria
  • age < 45
  • non metastatic breast cancer
  • at least 6 months of relationship
Exclusion Criteria
  • no life partner
  • inclusion criteria failure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Within chemotherapyinterview30 couples, interviewed within chemotherapy (6 to 8 months after diagnosis)
within Herceptininterview30 couples, within herceptin treatment (the first year after diagnosis)
within hormonotherapyinterview30 couples, within hormonotherapy (between 2 and 7 years after diagnosis)
without hormonotherapyinterview30 couples, did not received hormonotherapy (1 year after diagnosis)
end of treatmentinterview30 couples, after end of treatments for patients who did received hormonotherapy (7 years after diagnosis)
Primary Outcome Measures
NameTimeMethod
quality of life at different time of medical follow up6 months after diagnosis, 1 year after diagnosis, between 2 and 7 years after diagnosis, 7 years past diagnosis

interviews with couples at different time frame depending on which group they are in

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

François Baclesse Center

🇫🇷

Caen, France

Hospital

🇫🇷

Valenciennes, France

Gustave Roussy Institut

🇫🇷

Paris, France

Oscar Lambret Center

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath